Literature DB >> 15335219

Transduction of multiple cell types using improved conditions for gene delivery and expression of SV40 pseudovirions packaged in vitro.

Chava Kimchi-Sarfaty1, Nathan S Alexander, Scott Brittain, Saadia Ali, Michael M Gottesman.   

Abstract

This comprehensive study demonstrates highly efficient transduction of a wide variety of human, murine, and monkey cell lines, using a procedure for in vitro packaging of plasmid DNA in recombinant simian virus 40 (SV40) capsid proteins to form pseudovirions. The pseudovirions are encapsidated by the VP1 major capsid protein, with no SV40 sequence requirement, and are able to carry up to 17.7 kb of supercoiled plasmid DNA. We developed a procedure to scale-up production of SV40 pseudovirions, as well as an efficient protocol to concentrate the virions with no loss of activity. We also developed a method that allows transduction of 10 times more cells than the original protocol. This protocol was tested using supercoiled in vitro-packaged plasmid carrying the human multidrug-resistance gene (MDR1 encoding P-glycoprotein; P-gp), or the enhanced green fluorescent protein reporter gene (EGFP) in .45 human lymphoblastoid cells and in K562 human erythroleukemia cells. Multiple transductions at 24-h intervals were shown to increase expression using the EGFP reporter gene. The protocols developed in this study establish in vitro-packaged SV40 pseudovirions as one of the most efficient gene delivery systems.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15335219     DOI: 10.2144/04372RR04

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  9 in total

1.  Different approaches for assaying melanosome transfer.

Authors:  Werner Berens; Karolien Van Den Bossche; Tae-Jin Yoon; Wendy Westbroek; Julio C Valencia; Coby J Out; Jean Marie Naeyaert; Vincent J Hearing; Jo Lambert
Journal:  Pigment Cell Res       Date:  2005-10

2.  Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation.

Authors:  Thomas G Magaldi; Laura L Almstead; Stefania Bellone; Edward G Prevatt; Alessandro D Santin; Daniel DiMaio
Journal:  Virology       Date:  2011-11-05       Impact factor: 3.616

3.  Efficient delivery of RNA interference effectors via in vitro-packaged SV40 pseudovirions.

Authors:  Chava Kimchi-Sarfaty; Scott Brittain; Susan Garfield; Natasha J Caplen; Qingquan Tang; Michael M Gottesman
Journal:  Hum Gene Ther       Date:  2005-09       Impact factor: 5.695

4.  Scaffold properties are a key determinant of the size and shape of self-assembled virus-derived particles.

Authors:  Stanislav Kler; Joseph Che-Yen Wang; Mary Dhason; Ariella Oppenheim; Adam Zlotnick
Journal:  ACS Chem Biol       Date:  2013-10-23       Impact factor: 5.100

5.  Effect of dsDNA on the Assembly Pathway and Mechanical Strength of SV40 VP1 Virus-like Particles.

Authors:  Mariska G M van Rosmalen; Chenglei Li; Adam Zlotnick; Gijs J L Wuite; Wouter H Roos
Journal:  Biophys J       Date:  2018-09-13       Impact factor: 4.033

6.  Inhibition of multidrug resistance by SV40 pseudovirion delivery of an antigene peptide nucleic acid (PNA) in cultured cells.

Authors:  Benjamin Macadangdang; Ning Zhang; Paul E Lund; Andrew H Marple; Mitsunori Okabe; Michael M Gottesman; Daniel H Appella; Chava Kimchi-Sarfaty
Journal:  PLoS One       Date:  2011-03-22       Impact factor: 3.240

7.  Revealing in real-time a multistep assembly mechanism for SV40 virus-like particles.

Authors:  Mariska G M van Rosmalen; Douwe Kamsma; Andreas S Biebricher; Chenglei Li; Adam Zlotnick; Wouter H Roos; Gijs J L Wuite
Journal:  Sci Adv       Date:  2020-04-15       Impact factor: 14.136

8.  SV40 Pseudovirion gene delivery of a toxin to treat human adenocarcinomas in mice.

Authors:  C Kimchi-Sarfaty; W D Vieira; D Dodds; A Sherman; R J Kreitman; S Shinar; M M Gottesman
Journal:  Cancer Gene Ther       Date:  2006-02-24       Impact factor: 5.854

9.  DNA-free recombinant SV40 capsids protect mice from acute renal failure by inducing stress response, survival pathway and apoptotic arrest.

Authors:  Veronika Butin-Israeli; Dotan Uzi; Mahmoud Abd-El-Latif; Galina Pizov; Arieh Eden; Yosef S Haviv; Ariella Oppenheim
Journal:  PLoS One       Date:  2008-08-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.